Introduction
A highlight of the annual AJEI conference is UC Berkeley Law Dean Erwin Chemerinsky’s summary and analysis of recent Supreme Court decisions. The Dean spoke to a packed room at November’s conference in Boston, sharing his usual thorough recap of some of the more noteworthy civil cases decided in the past term.
The Term started October 2, 2023 and ended October 6, 2024 (OT’23). Dean Chemerinsky introduced the Term by quoting Justice Sotomayor in a talk she gave at Berkeley in January 2024. When he asked her, “How are you?,” she said, “I’m exhausted,” seemingly referring to the difficult cases the Court took up that Term.
The Dean pointed to the continuation of the Roberts Court’s trend of deciding significantly fewer cases each term than the Rehnquist Court, with the justices’ issuing only 59 signed decisions after briefing and oral argument this Term, on par with the previous three terms (58 in OT’22, 54 in OT’21, and 52 in OT’20). He extrapolated from these numbers that the Court is now “in a steady state,” deciding cases each term “somewhere in the 50s.”
He also noted that the Term’s decisions continued to reflect the Court’s solid conservative majority of six justices, with the Chief Justice finding himself as the justice most often in the majority (in 97% of the Term’s decisions, and dissenting in only one case). The Dean detected a more audible and “distinctive voice” from Justice Barrett as she directly encouraged her fellow justices to decide cases in a more moderate way, even though she almost always sided with her conservative brethren throughout the Term. Additionally, he shared his prediction that Justices Thomas and Alito will step down during the second administration of President Donald Trump.
The Cases
The Dean addressed the civil cases by subject matter, organizing them into the five categories of:
- Abortion
- The administrative state
- First Amendment
- Second Amendment
- Executive Power/Immunity.
Abortion
Two abortion cases came before the Court this Term, but the justices decided neither one on its merits.
Food & Drug Administration v. Alliance for Hippocratic Medicine (No. 23-235) involved mifepristone, a drug used to induce abortions. Following the Court’s June 2022 decision in Dobbs v. Jackson Women's Health Organization, which held there is no constitutional right to abortion, several states sought to restrict mifepristone’s sale. The Alliance for Hippocratic Medicine and other pro-life groups challenged the FDA’s approval of the drug, and both the trial court and the court of appeals sided with the plaintiffs, effectively banning the drug in the U.S. But the Court reversed in a unanimous decision written by Justice Kavanaugh, concluding that the plaintiffs lacked Article III standing to challenge the FDA’s regulatory actions regarding the drug. The Court reasoned that none of the plaintiff doctors or medical associations prescribes or uses mifepristone, and they do not allege direct monetary, property, or physical injuries from the FDA's regulation of the drug. Simply because they have legitimate legal, moral, ideological, and policy concerns about abortion does not suffice on its own to confer Article III standing to sue in federal court.
In a concurring opinion, Justice Thomas urged the Court (in a future case) to revisit its precedent that allows organizations and associations to sue in federal court, reiterating that associational (or organizational) standing is simply another form of third-party standing.
The other abortion case, Moyle v. United States (No. 23-736), started off with a bang, but ended with a fizzle. It involved the Emergency Medical Treatment and Labor Act (EMTALA), a law passed by Congress in 1986 that requires hospitals receiving Medicare funding to offer “necessary stabilizing treatment” to pregnant women in emergencies. Following Dobbs, the Biden Administration took aim at an Idaho law that criminalizes providing an abortion with narrow exceptions that include to save the life of the mother, arguing that the state law is preempted by EMTALA. After the trial court preliminarily enjoined the law, the Justices stayed the injunction and agreed to hear the case. But ultimately, in a 6-3 per curiam decision, the Court determined that it was premature for the justices to hear the case at this stage, returning the case to the Ninth Circuit for further proceedings.
The Administrative State
Probably the most widely discussed and noteworthy decision of the Term was in a pair of cases that squarely took aim at the Chevron doctrine of judicial deference to agency interpretations on the meaning of federal laws, Loper Bright Enterprises v. Raimondo (No. 22-1219) and Relentless, Inc. v. Department of Commerce (No. 22-1219). Divided 6-3, with the majority’s decision written by the Chief Justice, the Court overturned the doctrine established through its 1984 decision in Chevron U.S.A. v. Natural Res. Defense Council, Inc. Citing Marbury v. Madison, Chief Justice Roberts reasoned that the Administrative Procedure Act requires federal courts to “decide all relevant questions of law” when reviewing agency actions, meaning that judges should use their own judgment to interpret laws and not defer to agencies’ interpretations. In contrast, Chevron contradicted this fundamental Article III principle by requiring courts to defer to agency interpretations of ambiguous statutes if those interpretations were reasonable, premised on a flawed assumption that Congress intends to delegate interpretive authority to agencies whenever a law is ambiguous.
Justice Kagan dissented, joined by Justices Sotomayor and Jackson, stressing the doctrine of stare decisis and arguing that if Congress didn’t like the Chevron doctrine, Congress could have changed the APA to eliminate Chevron deference in the intervening 40 years since the Court’s Chevron decision.
In another 6-3 decision, Securities & Exchange Commission v. Jarkesy (No. 22-859), the Court held that the Seventh Amendment entitles a defendant to a jury trial when the SEC seeks civil penalties for securities fraud. The case involved an administrative law judge’s finding that Mr. Jarkesy was guilty of securities fraud, which led to the SEC’s imposition of civil penalties. Writing for the majority, Chief Justice Roberts reasoned that such matters must be decided by a jury, not by a non-Article-III body, despite Congress’s assignment of such enforcement actions to an agency. He explained that the claims are “legal in nature,” closely resembling common law fraud actions, in substance. He also emphasized that the SEC’s civil penalties here are punitive in nature, a type of remedy traditionally provided by courts of law and historically adjudicated by courts with juries. Justice Sotomayor’s dissenting opinion highlights the practical effects of the majority’s decision — that it will affect many agencies imposing civil penalties in administrative or enforcement proceedings. Along the same lines, Dean Chemerinsky noted the decision’s effects on the judiciary, as these administrative enforcement actions will now land in federal court.
The Court’s focus on the administrative state was also seen in Corner Post, Inc. v. Board of Governors of the Federal Reserve System (No. 22-1008). What seemed like a run-of-the-mill case about a statute of limitations, turned out to significantly increase agency exposure under the Administrative Procedure Act. The case involved the six-year statute of limitations for seeking judicial review of federal agency rulemaking under the APA, presenting whether one must challenge the validity of an agency rule within six years of the rule’s issuance or, instead, within six years from when the rule first injures the particular claimant. In another 6-3 decision, Justice Barrett wrote the majority opinion, holding that the limitations period runs once the particular claimant has been harmed by the agency action. Justice Jackson’s dissenting opinion, joined by Justices Sotomayor and Kagan, underscores the majority’s continued shift of power from agencies to courts, making it easier to challenge agency actions, and for a much longer period of time. Now, anytime one is aggrieved by an agency rule, no matter when that rule was enacted, the challenger has six years to bring suit under the APA.